11,560 Shares in CVS Health Co. (NYSE:CVS) Bought by Curat Global LLC

Curat Global LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS) during the first quarter, Holdings Channel.com reports. The fund purchased 11,560 shares of the pharmacy operator’s stock, valued at approximately $783,000.

A number of other hedge funds have also recently added to or reduced their stakes in CVS. LaFleur & Godfrey LLC raised its position in CVS Health by 49.9% during the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator’s stock worth $217,000 after acquiring an additional 1,610 shares during the period. Spire Wealth Management raised its position in CVS Health by 27.0% during the fourth quarter. Spire Wealth Management now owns 12,397 shares of the pharmacy operator’s stock worth $556,000 after acquiring an additional 2,634 shares during the period. Jennison Associates LLC acquired a new position in CVS Health during the fourth quarter worth $14,099,000. Yousif Capital Management LLC raised its position in CVS Health by 1.6% during the fourth quarter. Yousif Capital Management LLC now owns 225,627 shares of the pharmacy operator’s stock worth $10,128,000 after acquiring an additional 3,604 shares during the period. Finally, Y.D. More Investments Ltd acquired a new stake in shares of CVS Health in the fourth quarter valued at about $144,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS Health stock opened at $63.05 on Friday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The stock has a market cap of $79.76 billion, a P/E ratio of 17.23, a PEG ratio of 0.98 and a beta of 0.56. The company has a 50-day moving average price of $65.30 and a 200 day moving average price of $59.84. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. CVS Health’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 earnings per share. Sell-side analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.22%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health’s dividend payout ratio (DPR) is presently 63.48%.

Analyst Ratings Changes

Several research firms have recently weighed in on CVS. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Robert W. Baird raised their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 15th. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. UBS Group raised their price target on shares of CVS Health from $67.00 to $71.00 and gave the stock a “neutral” rating in a research note on Friday, May 2nd. Finally, JPMorgan Chase & Co. raised their price target on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 18th. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.